Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-89.57%
operating margin TTM
-101.94%
revenue TTM
158.63 Million
revenue per share TTM
1.03$
valuation ratios | |
|---|---|
| pe ratio | -9.52 |
| peg ratio | -0.32 |
| price to book ratio | 4.41 |
| price to sales ratio | 8.11 |
| enterprise value multiple | -11.35 |
| price fair value | 4.41 |
profitability ratios | |
|---|---|
| gross profit margin | 60.69% |
| operating profit margin | -101.94% |
| pretax profit margin | -89.57% |
| net profit margin | -89.57% |
| return on assets | -27.54% |
| return on equity | -99.8% |
| return on capital employed | -45.76% |
liquidity ratio | |
|---|---|
| current ratio | 2.89 |
| quick ratio | 2.89 |
| cash ratio | 2.72 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 4.79 |
| days of payables outstanding | 139.43 |
| cash conversion cycle | -134.64 |
| receivables turnover | 76.16 |
| payables turnover | 2.62 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.07 |
| debt equity ratio | 0.12 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.11 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -5.94 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.94 |
| cash per share | 1.87 |
| operating cash flow per share | -0.94 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -5.94 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -161.01 |
Frequently Asked Questions
When was the last time Wave Life Sciences Ltd. (NASDAQ:WVE) reported earnings?
Wave Life Sciences Ltd. (WVE) published its most recent earnings results on 30-09-2024.
What is Wave Life Sciences Ltd.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Wave Life Sciences Ltd. (NASDAQ:WVE)'s trailing twelve months ROE is -99.8%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Wave Life Sciences Ltd. (WVE) currently has a ROA of -27.54%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did WVE's net profit margin stand at?
WVE reported a profit margin of -89.57% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is WVE's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.89 in the most recent quarter. The quick ratio stood at 2.89, with a Debt/Eq ratio of 0.12.